Abstract

Purpose: SABR is standard practice for peripheral early stage lung cancer patients' who are medically inoperable. SABR was implemented from July 2014 at our centre. As part of quality reassurance, we analysed the survival outcomes and early toxicity of data in our patients.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call